Therapeutic Asset Ratings
3,171 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Eb-G3B7-Nk Dual-Target Car-Nk Cells
Hepatocellular Carcinoma
Beijing Biotech
P1/2
CC
(45)
Eb-Select Single-Target Car-Nk Cells
Acute Myeloid Leukemia
Essen Biotech
P1/2
CC
(45)
Eb-Select Single-Target Car-Nk Cells
Cutaneous Melanoma
Essen Biotech
P1/2
CC
(45)
Eb-Select Single-Target Car-Nk Cells
Non-Hodgkin Lymphoma
Essen Biotech
P1/2
CC
(45)
E-Edv-D682
Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited
P1/2
CC
(45)
et140203 t cells
Liver And Intrahepatic Bile Duct Neoplasm
Eureka Therapeutics Inc.
P1/2
CC
(45)
Fully Human Bcma Chimeric Antigen Receptor Autologous T Cell
Plasma Cell Myeloma
Nanjing IASO Biotechnology Co., Ltd.
P1/2
CC
(45)
gd2-cart01
Ewing Sarcoma
Bambino Gesù Hospital and Research Institute
P1/2
CC
(45)
gd2-cart01
Neuroblastoma
Bambino Gesù Hospital and Research Institute
P1/2
CC
(45)
gd2-cart01
Osteosarcoma
Bambino Gesù Hospital and Research Institute
P1/2
CC
(45)
Gdkm-100
Hepatocellular Carcinoma
Guangdong GD Kongming Biotech LLC
P1/2
CC
(45)
Gic-102
Plasma Cell Myeloma
GI Cell, Inc.
P1/2
CC
(45)
gpc3-car-t cells
Cutaneous Neuroendocrine Carcinoma
Sotio Biotech Inc.
P1/2
CC
(45)
gpc3-cart cells
Hepatocellular Carcinoma
Chinese PLA General Hospital
P1/2
CC
(45)
gpc3 cd146 car-t cells
Ovarian Carcinoma
Essen Biotech
P1/2
CC
(45)
Hnsc-01
Huntington Disease
Leslie Thompson
P1/2
CC
(45)
IM19 CAR-T cells
Neoplasm
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(45)
Ineo-Vac-T01 Personalized T Cell
Hepatocellular Carcinoma
Zhejiang University
P1/2
CC
(45)
Ksq-001Ex
Head And Neck Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Memory-Like Natural Killer Cells
Childhood Acute Myeloid Leukemia
Washington University School of Medicine
P1/2
CC
(45)
mt-101
Mycosis Fungoides
Myeloid Therapeutics
P1/2
CC
(45)
Neoantigen Specific Tcr-T Cell Drug Product
Female Reproductive Organ Cancer
Alaunos Therapeutics
P1/2
CC
(45)
Neoantigen Specific Tcr-T Cell Drug Product
Ovarian Carcinoma
Alaunos Therapeutics
P1/2
CC
(45)
New Donor-Derived Cd7 Car T-Cell
Acute Lymphoblastic Leukemia
Beijing GoBroad Hospital
P1/2
CC
(45)
New Donor-Derived Cd7 Car T-Cell
T-Cell Acute Lymphoblastic Leukemia
Beijing GoBroad Hospital
P1/2
CC
(45)
Showing 926 to 950 of 3,171 assets
Previous
Page 38 of 127
Next